StockData

Nutra Pharma Corp (NPHC) stock

NPHCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 1/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $806.69KP/E –Yield –

Nutra Pharma operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Nutra Pharma's operating cash flow for the twelve months ending Jun 30, 2026 was -$1.05M. For fiscal 2025 it was -$1.16M. The highest annual figure on record is -$148.13K in fiscal 2014.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$1.16M–
FY2024Dec 31, 2024-$423.96K–
FY2023Dec 31, 2023-$550.04K–
FY2022Dec 31, 2022-$762.43K–
FY2021Dec 31, 2021-$1.74M–
FY2020Dec 31, 2020-$878.09K–
FY2019Dec 31, 2019-$743.66K–
FY2018Dec 31, 2018-$999.95K–
FY2017Dec 31, 2017-$1.14M–
FY2016Dec 31, 2016-$1.36M–
FY2015Dec 31, 2015-$1.02M–
FY2014Dec 31, 2014-$148.13K–
FY2013Dec 31, 2013-$531.04K–
FY2012Dec 31, 2012-$721.24K–
FY2011Dec 31, 2011-$1.89M–
FY2010Dec 31, 2010-$1.36M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$251.22K–
Q1 FY2026Mar 31, 2026-$327.79K–
Q4 FY2025Dec 31, 2025-$219.82K–
Q3 FY2025Sep 30, 2025-$250.77K-1414.8%
Q2 FY2025Jun 30, 2025-$288.37K–
Q1 FY2025Mar 31, 2025-$405.01K–
Q4 FY2024Dec 31, 2024-$178.21K–
Q3 FY2024Sep 30, 2024$19.07K–
Q2 FY2024Jun 30, 2024-$93.62K–
Q1 FY2024Mar 31, 2024-$171.20K–
Q4 FY2023Dec 31, 2023-$186.23K–
Q3 FY2023Sep 30, 2023-$84.19K–
Q2 FY2023Jun 30, 2023-$186.84K–
Q1 FY2023Mar 31, 2023-$92.78K–
Q4 FY2022Dec 31, 2022-$54.03K–
Q3 FY2022Sep 30, 2022-$165.34K–
Q2 FY2022Jun 30, 2022-$284.83K–
Q1 FY2022Mar 31, 2022-$258.23K–
Q4 FY2021Dec 31, 2021-$233.68K–
Q3 FY2021Sep 30, 2021-$412.92K–
Q2 FY2021Jun 30, 2021-$503.54K–
Q1 FY2021Mar 31, 2021-$594.33K–
Q4 FY2020Dec 31, 2020-$352.82K–
Q3 FY2020Sep 30, 2020-$137.05K–
Q2 FY2020Jun 30, 2020-$172.65K–
Q1 FY2020Mar 31, 2020-$215.56K–
Q4 FY2019Dec 31, 2019-$308.72K–
Q3 FY2019Sep 30, 2019-$151.24K–
Q2 FY2019Jun 30, 2019-$192.20K–
Q1 FY2019Mar 31, 2019-$91.50K–
Q4 FY2018Dec 31, 2018-$136.05K–
Q3 FY2018Sep 30, 2018-$162.93K–
Q2 FY2018Jun 30, 2018-$352.66K–
Q1 FY2018Mar 31, 2018-$348.31K–
Q4 FY2017Dec 31, 2017-$226.39K–
Q1 FY2017Mar 31, 2017-$371.48K–
Q2 FY2016Jun 30, 2016-$283.14K–
Q1 FY2016Mar 31, 2016-$265.73K–

More Nutra Pharma figures

See a number that looks wrong?